Comparison of the effect of using ketamine and midazolam compared to propofol and midazolam on vital signs during gastroduodenoscopy in children referred to Bandar Abbas medical centers

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230228057558N1

Enrollment

Registered

2023-11-27

Start date

2023-11-22

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal problems. Diseases of oesophagus, stomach and duodenum

Interventions

Intervention 1: Intervention group: 0.03 mg/kg of intravenous midazolam and 1 mg/kg of propofol 1% will be given intravenously and they will undergo endoscopy. Intervention 2: Intervention group: rece

Eligibility

Sex/Gender

All

Age

2 Years to 16 Years

Inclusion criteria

Inclusion criteria: Having informed consent Children aged 2 to 16 years ASA class 1 or 2 candidates for upper gastrointestinal endoscopy

Exclusion criteria

Exclusion criteria: Allergy to any of the drugs used in the study Emergency endoscopy Contraindications for prescribing ketamine (history of neurological and psychiatric diseases, history of brain space-occupying lesions, heart rhythm disorders)

Design outcomes

Primary

Measure	Time frame
The rate of sedation during pediatric gastroduodenoscopy. Timepoint: Before, during, and at the discharge from recovery. Method of measurement: Aldrete score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnaz Darban

Bandare-abbas University of Medical Sciences

Darban.sam@gmail.com+98 912 084 5006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026